The exports situation and other issues in pharmaceutical sector were discussed during a meeting convened by Commerce and Industry Minister Nirmala Sitharaman.
During the meeting with senior officers from Ministry of Health, DCGI, Department of Pharmaceuticals, Department of Biotechnology, Department of Commerce and Pharmexcil, the minister took stock of various issues and challenges confronted by the Indian pharma industry, the ministry said in a statement.
"A sector like pharma which is deeply rooted in science and is truly global in nature, a 'Think Tank' consisting of senior pharma professionals, CEOs, government officials, scientists, researchers and pharmacists can provide an ideal forum to identify bottlenecks and resolve various issues for overcoming challenges and promoting hassle free exports," it said.
Since the scientific breakthroughs in chemistry, biology, microbiology, physics and biotechnology impact development of this sector directly or indirectly, it was considered important to have a platform where all these developments are shared between academia, industry and scientific community for the larger benefit of the society.
Indian medicines have served humanity across all continents of the world and their contribution in fighting HIV and various other diseases in various developing countries has been particularly notable, it said.
By putting its act together, the Indian pharma sector can help the global community in its fight against various life threatening diseases, it added.
The sector significantly contributes in the country's total exports. Pharmaceuticals exports grew by 2.63 per cent to USD 15.34 billion in 2014-15.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
